Ch1- Lec 1- Intro to Drug and Pharmacy Flashcards
What is Pharmacy?
Pharmacy is the science, art, and practice of preparing, preserving, compounding, and dispensing medicinal drugs and of giving instructions for their use
Pharmacopeia’s or Formularies
- (First one in 1820) were created.
- These are organized sets of monographs or books of standards.
- Written with high degree of clarity and specificity
USP* and NF
- Adopt standards for drugs, pharmaceutical ingredients and dosage forms
- Reflect the best current practices of medicine
- Provides information on tests and assay procedures for demonstrating compliance with these standards
- For individual components not combinations
Pharmaceutical Care
“The mission of the pharmacist is to provide pharmaceutical care: “a practice in which the practitioner takes responsibility for a patient’s drug-related needs and is held accountable for this commitment”
Food and Drug Act of 1906:
Was the very first Federal Law in the U.S. that required that “drugs marketed interstate comply with claimed standards for strength, purity and quality”.
Manufacturer’s claims of therapeutic benefit in 1912.
In this case, the Sherley Amendment said,
No More False Claims
Declared Products Misbranded
The Federal Food, Drug, and Cosmetic Act of 1938
What did it provide?
- Required that all new drugs be tested by their manufacturers for safety.
- Required that those tests be submitted to the government for marketing approval via the NDA (new drug application)
- Mandated that drugs be labeled with adequate directions
- Authorized FDA to conduct unannounced inspections
- No new drug could be distributed without the prior filing of a new drug application (NDA), and approval of the FDA.
- The FDA now dealt with safe use of drug substances, but did not require that the drugs be (efficacious) effective in the treatment of disease
The FDA was given the job to grant/deny products entering the market, based on
- Product’s ingredients
- Methods used to evaluate products
- Standards used to evaluate formulations
- Preclinical studies
- Pharmacology
- Toxicology
- Clinical trials
- Still, FDA did not require drugs to be efficacious
What is the difference between the FDA acts of 1906 and of 1938?
SAFETY
FDA Act of 1938- Required that all new drugs be tested by their manufacturers for safety..
FDA Act of 1906- dealt with strength, purity and quality of drugs
Kefauver-Harris Amendments of 1962
- Thalidomide Tragedy was the main reason behind the development of this Act.
- This amendment required manufacturers to prove a drug to be both safe as well as efficacious before granting FDA approval for marketing.
- Exempted from both safety and efficacy requirements were drugs that happened to enter the market between 1906 and 1938 aka ~ grandfather clause. Why? Drugs were never subjected to NDAs.
Durham-HumphreyAmendment of 1952
- No refills (dispensing of drugs) without a valid prescription
- This clarified dispensing obligations of pharmacists
- Defined drugs that cannot be used safely without proper medical supervision
- Determined what drugs are OTC (over-the-counter) and what drugs are not available OTC
- Refilling necessary only if authorized in prescription
- Further supported by the drug abuse control amendments of 1965
- and the Comprehensive drug abuse prevention and control Act of 1970.
Comprehensive Drug Abuse Prevention and Control Act of 1970
- Drugs of abuse were put under a comprehensive regulatory framework
- The act established 5 “schedules for classification and control of drug substances particularly those that were more likely to be abused
FDA Pregnancy Categories
- 1979- US FDA introduced classification of fetal risks due to pharmaceutical agent use
- What is the Risk vs Benefit Ratio?
- Category A: Studies failed to demonstrate risk to fetus (1st trimester- no evidence of risk in later trimester)
- Category B
- Category C
- Category D
- Category X: Animal studies or humans demonstrated fetal abnormalities. Women outweigh potential benefits
- See pg 15 (table 1 for known teratogens)
“Black Box” Warnings
- FDAs absolute strongest labeling requirements used for the highest risk medications.
- It stresses importance of close patient monitoring when using the medications.
- No “reminder ads” for health care professionals allowed
- Local and State Law may only strengthen FDA laws, never weaken them.
Schedule I, II, III, IV & V
- The schedules provide decreasing levels of control from schedule I to schedule V.
- Schedule I & II are high potential: ex.Heroin for schedule I
- Schedule III is moderate potential: ex. Codein
-
Schedule IV&V are low potential: ex. Diazepam for schedule IV__________________________________________
Examples were taken directly from text. See notes and Chapter #1 (page 13-14 ) for other examples
Drug Listing Act of 1972
- “Each firm that manufactures or repackages drugs for the ultimate sale or distribution to patients or consumers must register with the FDA and submit appropriate information for listing”
- National Drug Code (NDC) permanent registration code to identify manufacturer or distributor.
- The code is 10 digits long
National Drug Code (NDC)
** “Labeler code” “Product code” “Package code”**
** How is one different from the other?
Example of NDC: NDC 0081-5421-12**
Labeler code: Manufacturer/ distributor (1st 4 digits)
Product code: Used to identify drug formulation (3-4)
Package code: Used to identify package size & type (3-2)
National Drug Code
** NDC 0081-5421-12**
Represents 4-2 digit product-code-package-code configuration
** NDC 0057-346-421**
Represents 3-3 digit product-code-package-code configuration
Drug Price Competition and Patent Term Restoration Act of 1984
A demand to change the speed for approving generic compounds
Generic drugs must be bioequivalent to brand-name drugs
This resulted in new modifications to FDA guidelines to “accelerate the approval of generic drugs, and to extend the life of innovative patented technology”
Ronald Reagen signed law on 9/24/84 to make generic drugs more widely available
Concerns of Pharmacists:
FDA criteria for bioequivalence, what about therapeutic index?
Under the ANDA
- In order to encourage pioneering research efforts and innovative drug development the life of patents was extended.
- This time was extended to the amount of time required to review the NDA,
- plus half the time required to evaluate the drug in the testing phase.
Abbreviated New Drug Application (ANDA)
- The Drug Price Competition and Patent Terms Restoration Act of 1984 said that,
- “Any originally approved new drug can be filed through an ANDA and bypass animal and human study testing.”
- This reduced the time and money to market the generic version of a drug compound.
Prescription DrugMarketing Act of 1987
Aka “Dingell Bill”
This act prohibits reimportation of drugs, prohibits sales, trading and purchasing of drugs.
*******************Why important?****************
Functioned to protect the supply of prescription agents and prevent repackaged and mislabeled drugs from entering the legitimate market